Reintroduction of C/EBPα in leukemic CD34+ stem/progenitor cells impairs self-renewal and partially restores myelopoiesis

被引:38
作者
Schepers, Hein
Wierenga, Albertus T. J.
van Gosliga, Djoke
Eggen, Bart J. L.
Vellenga, Edo
Schuringa, Jan Jacob [1 ]
机构
[1] Univ Med Ctr, Dept Med, Div Hematol, Groningen, Netherlands
[2] Univ Groningen, Dept Dev Genet, Groningen, Netherlands
关键词
D O I
10.1182/blood-2006-10-052175
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The CCAAT/enhancer binding protein (C/EBP) a transcription factor is indispensable for myeloid differentiation. In various myeloid leukemias, C/EBP alpha is mutated or functionally impaired due to decreased C/EBP alpha expression or phosphorylation. In order to investigate the functional consequences of decreased C/EBP alpha. function in AML, we reintroduced C/EBP alpha in primary CD34(+) sorted acute myeloid leukemia (AML) cells using a lentiviral approach. Self-renewal and differentiation of primary AML stem cells were studied on long-term MS5 cocultures. Activation of C/EBP alpha- immediately led to a growth arrest in all AML cultures (N = 7), resulting in severely reduced expansion compared with control cultures. This growth arrest corresponded with enhanced myeloid differentiation as assessed by fluorescence-activated cell sorter (FACS) analysis for CD14, CD15, and CD11b. Myeloid differentiation was further confirmed by the up-regulation of neutrophil elastase and granulocyte colony-stimulating factor (G-CSF) receptor in C/EBP alpha transduced cells. C/EBP alpha-expressing AML CD34+ cells failed to generate second and third leukemic cobblestone areas (L-CAs) in serial replating experiments, while control cultures could be sequentially passaged for more than 4 times, indicating that reintroduction of C/EBP alpha impaired the self-renewal capacity of the leukemic CD34+ compartment. Together, our data indicate that low C/EBP alpha. levels are necessary to maintain self-renewal and the immature character of AML stem cells.
引用
收藏
页码:1317 / 1325
页数:9
相关论文
共 31 条
[1]
Detection and characterization of primitive malignant and normal progenitors in patients with acute myelogenous leukemia using long-term coculture with supportive feeder layers and cytokines [J].
Ailles, LE ;
Gerhard, B ;
Hogge, DE .
BLOOD, 1997, 90 (07) :2555-2564
[2]
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages [J].
Akashi, K ;
Traver, D ;
Miyamoto, T ;
Weissman, IL .
NATURE, 2000, 404 (6774) :193-197
[3]
Induction of C/EBPα activity alters gene expression and differentiation of human CD34+ cells [J].
Cammenga, J ;
Mulloy, JC ;
Berguido, FJ ;
MacGrogan, D ;
Viale, A ;
Nimer, SD .
BLOOD, 2003, 101 (06) :2206-2214
[4]
Infrequent hypermethylation of CEBPA promotor in acute myeloid leukaemia [J].
Chim, CS ;
Wong, ASY ;
Kwong, YL .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (04) :988-990
[5]
Leukemogenesis induced by wild-type and ST157 1-resistant BCR/ABL is potently suppressed by C/EBPα [J].
Ferrari-Amorotti, Giovanna ;
Keeshan, Karen ;
Zattoni, Michela ;
Guerzoni, Clara ;
Iotti, Giorgio ;
Cattelani, Sara ;
Donato, Nick J. ;
Calabretta, Bruno .
BLOOD, 2006, 108 (04) :1353-1362
[6]
Garwicz D, 2005, HAEMATOLOGICA, V90, P38
[7]
Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein α in myelodysplastic syndromes and acute myeloid leukemias [J].
Gombart, AF ;
Hofmann, WK ;
Kawano, S ;
Takeuchi, S ;
Krug, U ;
Kwok, SH ;
Larsen, RJ ;
Asou, H ;
Miller, CW ;
Hoelzer, D ;
Koeffler, HP .
BLOOD, 2002, 99 (04) :1332-1340
[8]
C/EBPα deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo [J].
Heath, V ;
Suh, HC ;
Holman, M ;
Renn, K ;
Gooya, JM ;
Parkin, S ;
Klarmann, KD ;
Ortiz, M ;
Johnson, P ;
Keller, J .
BLOOD, 2004, 104 (06) :1639-1647
[9]
CBFB-SMMHC is correlated with increased calreticulin expression and suppresses the granulocytic differentiation factor CEBPA in AML with inv(16) [J].
Helbling, D ;
Mueller, BU ;
Timchenko, NA ;
Schardt, J ;
Eyer, M ;
Betts, DR ;
Jotterand, M ;
Meyer-Monard, S ;
Fey, MF ;
Pabst, T .
BLOOD, 2005, 106 (04) :1369-1375
[10]
The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of Calreticulin [J].
Helbling, D ;
Mueller, BU ;
Timchenko, NA ;
Hagemeijer, A ;
Jotterand, M ;
Meyer-Monard, S ;
Lister, A ;
Rowley, JD ;
Huegli, B ;
Fey, MF ;
Pabst, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (36) :13312-13317